SCHEMBL19543729

SCHEMBL19543729

c1ccc(-c2ccc(-c3nc(-c4ccccc4)nc(-c4ccc5cc(-c6cccc7c6-c6ccccc6C7(c6ccccc6)c6ccccc6)ccc5c4)n3)cc2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 6/20 0.36
KMT2A Q03164 6/20 0.36
MAPT P10636 4/20 0.36
KDM4E B2RXH2 3/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
LMNA P02545 2/20 0.36
OPRK1 P41145 1/20 0.36
ALDH1A1 P00352 3/20 0.34
HPGD P15428 3/20 0.34
ADORA2A P29274 3/20 0.34
ADORA1 P30542 3/20 0.34
ADORA3 P0DMS8 2/20 0.34
ADORA2B P29275 2/20 0.34
CYP1A2 P05177 2/20 0.34
TP53 P04637 1/20 0.34
HSD17B10 Q99714 1/20 0.34
ALOX15 P16050 1/20 0.34
TSHR P16473 1/20 0.34
GLA P06280 1/20 0.33
ESR2 Q92731 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18386122 0.95 MEN1 (0.36) MEN1KMT2AMAPTKDM4ESMN1; SMN2
SCHEMBL17932285 0.95 MEN1 (0.37) MEN1KMT2AMAPTKDM4ESMN1; SMN2
SCHEMBL21394091 0.95 MEN1 (0.37) MEN1KMT2AMAPTKDM4ESMN1; SMN2
SCHEMBL20465271 0.95 MEN1 (0.37) MEN1KMT2AMAPTKDM4ESMN1; SMN2
SCHEMBL22059123 0.94 HDAC4 (0.37) MEN1KMT2AMAPTKDM4ESMN1; SMN2
SCHEMBL18463431 0.94 MEN1 (0.39) MEN1KMT2AMAPTKDM4ESMN1; SMN2
SCHEMBL21394092 0.94 MEN1 (0.36) MEN1KMT2AMAPTKDM4ESMN1; SMN2
SCHEMBL20465268 0.94 MEN1 (0.36) MEN1KMT2AMAPTKDM4ESMN1; SMN2
SCHEMBL20465270 0.94 MEN1 (0.36) MEN1KMT2AMAPTKDM4ESMN1; SMN2
SCHEMBL17151577 0.92 MEN1 (0.37) MEN1KMT2AMAPTKDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11329230-B2 Organic light-emitting device SAMSUNG DISPLAY CO., LTD. (KR) 2022-05-10 US disclosed
US-20170317294-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2017-11-02 US disclosed
US-20170317294-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2017-11-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11329230-B2 Organic light-emitting device EML4, SUN2, TRPA1 MEN1 2816/4885KMT2A 1971/4885MAPT 735/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.